Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sagent Pharm Inc (SGNT)

Sagent Pharm Inc (SGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Sagent Pharmaceuticals, Inc. is a pharmaceutical company that develops and sources products with primary focus on generic injectable pharmaceuticals. Products offered by the Company cover a range of anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled, ready-to-use syringes, medical devices and premix bags. Sagent Pharmaceuticals, Inc. is is based in Schaumburg, Illinois.

Fiscal Year End Date: 12/31

(Values in U.S. Thousands) Dec, 2015 Dec, 2014 Dec, 2013 Dec, 2012 Dec, 2011
Sales 318,300 288,980 244,750 183,620 152,410
Sales Growth +10.15% +18.07% +33.29% +20.48% +105.82%
Net Income -21,880 39,880 29,590 -16,820 -26,420
Net Income Growth -154.86% +34.78% +275.92% +36.34% -7.88%
(Values in U.S. Thousands) Dec, 2015 Dec, 2014 Dec, 2013 Dec, 2012 Dec, 2011
Total Assets 349,730 381,490 310,210 172,320 230,510
Total Assets Growth -8.33% +22.98% +80.02% -25.24% +94.39%
Total Liabilities 98,640 105,740 74,180 40,460 88,840
Total Liabilities Growth -6.71% +42.55% +83.34% -54.46% -58.75%
(Values in U.S. Thousands) Dec, 2015 Dec, 2014 Dec, 2013 Dec, 2012 Dec, 2011
Operating Cash Flow -7,520 23,180 49,550 -20,120 -20,420
Operating Cash Flow Growth -132.44% -53.22% +346.27% +1.47% +26.52%
Net Cash Flow -26,670 13,300 14,650 -24,520 17,830
Change in Net Cash Flow -300.53% -9.22% +159.75% -237.52% -33.07%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar